Signaling pathways activated by interferons

Experimental Hematology

Volumn 27, Issue 11, 1999, Pages 1583-1592

  Platanias, Leonidas C ^a   Fish, Eleanor N ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Interferons; Signal transduction

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CELL PROTEIN; GAMMA INTERFERON; INSULIN RECEPTOR SUBSTRATE 1; INTERFERON; INTERFERON RECEPTOR; ONCOPROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

GROWTH INHIBITION; HEMATOPOIESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0032727032     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00109-5     Document Type: Review

References (144)

1. Petska S., Langer J.A., Zoon K.C., Samuel C.E. Interferons and their actions. Annu Rev Biochem. 56:1987;727.
2. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., Screiber R.D. How cells respond to interferons. Annu Rev Biochem. 67:1998;227.
3. Platanias L.C. Interferons. Laboratory to clinic investigations. Curr Opin Oncol. 7:1995;560.
4. Pfeffer L.M., Dinarello C.A., Herberman Rbm, Williams B.R., Borden E.C., Bordens R., Walter M.R., Nagabbushan T.L., Trotta P.P., Pestka S. Biological properties of recombinant human alpha-interferons:40th anniversary of the discovery of interferons. Cancer Res. 58:1998;2489.
5. Diaz M.O., Pomycala H., Bohlander S., Maltepe E., Malik K., Brownstein B., Olopade O.I. Structure of the human Type I interferon gene cluster determined from a YAC clone contig. Genomics. 22:1994;540.
6. Ortega J.A., Ma A., Shore N.A., Dukes P.P., Merigan T.C. Suppressive effect of interferon on erythroid cell proliferation. Exp Hematol. 7:1979;145.
7. Klimpel G.R., Fleischmann W.R. Jr., Klimpel K.D. Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N. magnitude of suppression is dependent upon level of colony-stimulating factor (CSF) J Immunol. 129:1982;76.
8. Neumann H.A., Fauser A.A. Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow. Exp Hematol. 10:1982;5879.
9. Broxmeyer H.E., Lu L., Platzer E., Feit C., Juliano L., Rubin B.Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol. 131:1983;1300.
10. Raefsky E.L., Platanias L.C., Zoumbos N.C., Young N.S. Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol. 135:1985;2507.
11. Broxmeyer H.E., Cooper S., Rubin B.Y., Taylor M.W. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro. J Immunol. 135:1985;2502.
12. Delforge A., Vandenplas B., Lagenaux L., Loos M., Bron D., Debussher L., Stryckmans P. Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors. Eur J Haematol. 44:1990;307.
13. Ganser A., Carlo-Stella C., Greher J., Volkers B., Hoelzer D. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood. 1987 70:1987;1173.
14. Gugliotta L., Bagnara G.P., Catani L., Gaggioli L., Guarini A., Zauli G., Belmonte M.M., Lauria F., Macchi S., Tura S. In vivo and in vitro inhibitory effect of alpha-interferon on megakaryocyte colony growth in essential thrombocythaemia. Br J Haematol. 71:1989;177.
15. Means R.T. Jr., Krantz S.B. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest. 91:1993;416.
16. Weekx S.F., Van Bockstaele D.R., Plum J., Moulijn A., Rodrigus I., Lardon F., De Smedt M., Nijs G., Lenjou M., Loquet P., Berneman Z.N., Snoeck H.W. CD34+ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol. 26:1998;1034.
17. Uzé G., Lutfalla G., Mongensen K.E. α and β interferons and their receptor and their friends and relations. J Interferon Res. 15:1995;3.
18. Platanias L.C., Pfeffer L.M., Cruciani R., Colamonici O.R. Characterization of the α-subunit of the IFNα receptor. Evidence for N-and O-linked glycosylation and association with other surface proteins. J Immunol. 150:1993;3382.
19. Colamonici O.R., Domanski P. Identification of a novel subunit of the Type I interferon receptor localized to chromosome 21. J Biol Chem. 268:1994;10895.
20. Platanias L.C., Pfeffer L.M., Barton K., Vardiman J.W., Golomb H.M., Colamonici O.R. Expression of the IFNα receptor in hairy cell leukemia cells. Br J Haematol. 82:1992;541.
21. Colamonici O.R., Pfeffer L., D'Alessandro F., Platanias L.C., Rosolen A., Nordan R., Cruciani R.A., Diaz M.O. Multichain structure of the interferon alpha-2 receptor on hematopoietic cells. J Immunol. 148:1992;2126.
22. Uzé G., Lutfalla G., Gresser I. Genetic transfer of a functional human interferon α receptor into mouse cells:cloning and expression of its cDNA. Cell. 60:1990;225.
23. Lutfalla G., Holland S.J., Ginato E., Monneron D., Reboul J., Rogers N.C., Smith J.M., Stark G.R., Gardiner K., Mogensen K.E., Kerr I.M., Uzé G. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14:1995;5100.
24. Domanski P., Witte M., Kellum M., Rubinstein M., Hackett R., Pitha P., Colamonici O.R. Cloning and expression of a long form of the beta subunit of the interferon alpha/beta receptor that is required for signaling. J Biol Chem. 270:1995;21606.
25. Novick D., Cohen B., Rubinstein M. The human interferon α/β receptor. characterization and molecular cloning Cell. 77:1994;391.
26. Colamonici O.R., Domanski P., Krolewski J.J., Fu X.Y., Reich N.C., Pfeffer L.M., Sweet M.E., Platanias L.C. Interferon alpha signaling in cells expressing the variant form of the type I IFN receptor. J Biol Chem. 269:1994;5660.
27. Bach E.A., Aguet M., Screiber R.D. The IFN gamma receptor. a paradigm for cytokine receptor signaling Annu Rev Immunol. 15:1997;571.
28. Hemmi S., Bohni R., Stark G., DiMarco F., Aguet M. A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell. 76:1994;803.
29. Soh J., Donelly R.J., Kotenko S., Mariano T.M., Cook J.R., Wang N., Emanuel S., Schwartz B., Miki T., Pestka S. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell. 76:1994;793.
30. tyk2 an interferon-dependent tyrosine kinase, is physically associated with an interferon receptor. J Biol Chem. 269:1994;3518.
31. tyk2 tyrosine kinase. Mol Cell Biol. 14:1995;8133.
32. Uddin S., Chamdin A., Platanias L.C. Interaction of the transcriptional activator Stat-2 with the Type I IFN receptor. J Biol Chem. 270:1995;24627.
33. Domanski P., Fish E., Nadeau O.W., Witte M., Platanias L.C., Yan H., Krolewski J., Pitha P., Colamonici O.R. A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-stat pathway and induce an antiviral state. J Biol Chem. 272:1997;26388.
34. Müller M., Briscoe J., Laxton C., Guschin D., Ziemecki A., Silvennoinen O., Harpur A.G., Barbieri G., Witthun B.A., Schindler C., Pellegrini S., Wilks A.F., Ihle J.N., Stark G.R., Kerr I.M. The protein tyrosine kinase JAK-1 complements defects in interferon α/β and γ signal transduction. Nature. 366:1993;129.
35. Silvenoinen O., Ihle J.N., Schlessinger J., Levy D.E. Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature. 366:1993;583.
36. Platanias L.C., Colamonici O.R. Interferon α induces rapid tyrosine phosphorylation of the a subunit of its receptor. J Biol Chem. 267:1992;24053.
37. Platanias L.C., Uddin S., Colamonici O.R. Tyrosine phosphorylation of the α and β subunits of the Type I Interferon receptor. Interferon β selectively induces tyrosine phosphorylation of an α subunit associated protein. J Biol Chem. 27:1994;17761.
38. Abramovich C., Shulman L.M., Ratoviski E., Harroch S., Tovey M., Eid P., Revel M. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and an associated surface protein in response to IFNα and IFNβ EMBO J. 13:1994;5871.
39. L subunits of the type I interferon receptor. J Biol Chem. 271:1996;23630.
40. Croze E., Russell-Harde D., Wagner T.C., Pu H., Pfeffer L.M., Perez H.D. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. J Biol Chem. 271:1996;33165.
41. Fu X.-Y. A transcription factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic tyrosine kinase (s). Cell. 70:1992;323.
42. Schindler C., Shuai K., Prezioso V.R., Darnell Jr J.E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic factor. Science. 257:1992;809.
43. Gutch M.J., Daly C., Reich N.C. Tyrosine phosphorylation is required for activation of an α-interferon- stimulated transcription factor. Proc Natl Acad Sci U S A. 8:1992;11411.
44. Beadling C., Guschin D., Witthuhn B.A., Ziemiecki A., Ihle J.N., Kerr I.M., Cantrell D.A. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:1994;5605.
45. Darnell J.E. Jr. Stats and gene regulation. Science. 277:1997;1630.
46. Darnell J.E. Jr. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J Interf Cyt Res. 18:1998;549.
47. Meinke A., Barahmand-Pour F., Wohrl S., Stoiber D., Decker T. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol. 16:1996;6937.
48. Li X., Leung S., Kerr I.M., Stark G.R. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol. 17:1997;2048.
49. Nadeau O.W., Domanski P., Usacheva A., Uddin S., Platanias L.C., Pitha P., Raz R., Levy D., Majchrzak B., Fish E.N., Colamonici O.R. The proximal tyrosines of the cytoplasmic domain of the β subunit of the Type I interferon receptor are essential for Stat2 activation. Evidence that two Stat. 2(sites are required to reach a threshold of interferon α-induced Stat2 tyrosine phosphorylation that allows normal formation of ISGF3. J Biol Chem 274):1999;4045.
50. Mowen K., David M. Role of the Stat1-SH2 domain and Stat2 in the activation and nuclear translocation of Stat1. J Biol Chem. 273:1998;30073.
51. Yang C.H., Shi W., Basu L., Murti A., Constantinescu S.N., Blatt L., Croze E., Mullersman J.E., Pfeffer L.M. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem. 1996 271:1996;8057.
52. Yang C.H., Murti A., Pfeffer L.M. STAT3 complements defects in an interferon-resistant cell line. evidence for an essential role for STAT3 in interferon signaling and biological activities Proc Natl Acad Sci U S A. 95:1998;5568.
53. Pfeffer L.M., Mullersman J.E., Pfeffer S.R., Murti A., Shi W., Yang C.H. STAT3 as an adapter to couple phosphatidylinositol 3′-kinase to the IFNAR1 chain of the type I interferon receptor. Science. 276:1997;1418.
54. White M.F. The insulin signalling system and the IRS proteins. Diabetologia. 40(Suppl 2):1997;2.
55. Myers MG Jr, Sun X-J, White MF (1994) The IRS-1 signaling systemTIBS 19:289.
56. White M.F., Kahn C.R. The insulin signaling system. J Biol Chem. 269:1994;1.
57. White M.F. The IRS-signaling system. a network of docking proteins that mediate insulin action Mol Cell Biochem. 182:1998;3.
58. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:1991;73.
59. Sun X.J., Wang L.M., Zhang Y., Yenush L., Myers M.G. Jr., Glasheen E., Lane W.S., Pierce J.H., White M.F. Role of IRS-2 in insulin and cytokine signalling. Nature. 14:1995;173.
60. Lavan B.E., Lane W.S., Lienhard G.E. The 60 kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem. 272:1997;11439.
61. Lavan B.E., Fantin V.R., Chang E.T., Lane W.S., Keller S.R., Lienhard G.E. A novel 160 kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem. 272:1997;21403.
62. Holgado-Madruga M., Emlet D.R., Moscatello D.K., Godwin A.K., Wong A.J. A Grb-2 associated docking protein in EGF- and insulin-receptor signalling. Nature. 379:1996;560.
63. Gu H., Pratt J.C., Burakoff S.J., Neel B.G. Cloning of p97/Gab2, the major SHP-2- binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell Biol. 2:1998;729.
64. Uddin S., Yenush L., Sun X.-J., Sweet M.E., White M.F., Platanias L.C. Interferon α engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′- kinase. J BiolChem. 270:1995;15938.
65. Uddin S., Fish E.N., Sher D.A., Gardziola C., White M.F., Platanias L.C. Activation of the phosphatidylinositol 3′-kinase serine kinase by IFNα J Immunol. 158:1997;2390.
66. Platanias L.C., Uddin S., Yetter A., Sun X.-J., White M.F. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem. 271:1996;278.
67. Burfoot M.S., Rogers N.C., Watling D., Smith J.M., Pons S., Paonessaw G., Pellegrini S., White M.F., Kerr I.M. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem. 272:1997;241843.
68. Uddin S., Fish E.N., Sher D., Gardziola C., Colamonici O.R., Kellum M., Pitha P., White M.F., Platanias L.C. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon α receptors. Blood. 90:1997;2574.
69. Blake T.J., Shapiro M., Morse H.C., Langdon W.Y. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene. 6:1991;653.
70. Blake T.J., Heath K.G., Lagdon W.Y. The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation. EMBO J. 12:1993;2017.
71. Galisteo M.L., Dikic I., Batzer A.G., Langdon W.Y., Schlessinger J. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J Biol Chem. 270:1995;20242.
72. Meisner H., Czech M.P. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J Biol Chem. 270:1995;25332.
73. cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J Biol Chem. 271:1996;563.
74. Tanaka S., Neff L., Baron R., Levy J.B. Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem. 270:1995;14347.
75. Marcilla A., Rivero-Lezcano O.M., Agarwal A., Robbins K.C. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fcγ receptors. J Biol Chem. 270:1995;9115.
76. Donovan J.A., Wange R.L., Langdon W.Y., Samelson L.E. The protein product of the c-cbl proto-oncogene is the 120 kDa tyrosine phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem. 269:1994;22921.
77. Meisner H., Conway B.R., Hartley D., Czech M.P. Interactions of Cbl with Grb-2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. J Biol Chem. 15:1995;3571.
78. Wang Y., Yeung Y., Langdon W., Stanley E.R. C-Cbl is transiently tyrosine- phosphorylated, ubiquinated and membrane-targeted following CSF-1 stimulation of macrophages. J Biol Chem. 271:1996;17.
79. Odai H., Sasaki K., Iwamatsu A., Hanazono Y., Tanaka T., Mitani K., Yazaki Y., Hirai The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem. 270:1995;10800.
80. Rivero-Lezcano OM, Sameshima JH, Marcilla A, Robbins KC. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J Biol Chem 269:17363.
81. cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in Vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 271:1996;3187.
82. Andoniou C.E., Thien C.B.F., Langdon W.Y. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene. 12:1996;1981.
83. Uddin S., Gardziola C., Dangat A., Yi T., Platanias L.C. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochem Biophys Res Commun. 225:1996;833.
84. fyn with interferon-activated Jak kinases. Biochem Biophys Res Commun. 235:1997;83.
85. Ahmad S., Alsayed Y., Druker B.J., Platanias L.C. The Type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J Biol Chem. 272:1997;29991.
86. Mayer B.J., Hamaguchi M., Hanafusa H. A novel viral oncogene with structural homology to phospholipase C. Nature. 332:1998;272.
87. Sattler M., Salgia R. Role of the adapter protein CrkL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells. Leukemia. 12:1998;637.
88. BCR/ABL to the PI 3′-kinase pathway. Oncogene. 12:1996;839.
89. Reedquist K.A., Fukazawa T., Panchamoorthy G., Langdon W.Y., Shoelson S.E., Druker B.J., Band H. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine exchange protein C3G. J Biol Chem. 271:1996;8435.
90. Ribon V., Hubbell S., Herrera R., Saltiel A.R. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol Cell Biol. 16:1996;45.
91. Tanaka S., Morishita T., Hashimoto Y., Hattori S., Nakamura S., Shibua M., Matuoka K., Takenawa T., Kurata T., Nagashima K., Matsuda M. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A. 91:1994;3443.
92. Feller S.M., Knudsen B., Hanafusa H. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-CRK indicate Crk-specific signaling pathways. Oncogene. 10:1995;1465.
93. Gotoh T., Hattori S., Nakamura S., Kitayama H., Noda M., Takai Y., Kaibuchi K., Matsui H., Hatase O., Takahashi H., Kurata T., Matsuda M. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol. 15:1995;6746.
94. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 56:1989;77.
95. Kitayama H., Matsuzaki T., Ikawa Y., Noda M. Genetic analysis of the Kirsten- ras-revertant 1 gene:potentiation of its tumor suppressor activity by specific point mutations. Proc Natl Acad Sci U S A. 87:1990;4284.
96. Cook S., Rubinfeld B., Albert I., McCormick F. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:1993;3475.
97. Platanias L.C., Uddin S., Bruno E., Korkmaz M., Ahmad S., Alsayed Y., Van Den Berg D., Druker B.J., Wickrema A., Hoffman R. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp Hematol. 27:1999;1315.
98. Fish E.N., Uddin S., Korkmaz M., Majchrzak B., Druker B.J., Platanias L.C. Activation of a CrkL-Stat5 signaling complex by type I interferons. J Biol Chem. 274:1999;571.
99. Katzav S., Martin-Zanca D., Barbacid M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:1989;2283.
100. Katzav S., Cleveland J.L., Heslop H.E., Pulido D. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol. 11:1991;1912.
101. Galland F., Katzav S., Birnbaum D. The products of the mcf-2 and vav proto-oncogenes and of the yeast cdc-24 share sequence similarities. Oncogene. 7:1992;585.
102. Coppola J., Bryant S., Koda T., Conway D., Barbacid M. Mechanism of activation of the vav proto-oncogene. Cell Growth Differ. 2:1991;95.
103. Cantrell D. Lymphocyte signalling. a coordinating role for Vav? Curr Biol. 16:1998;535.
104. Romero F., Fischer S. Structure and function of vav. Cell Signal. 8:1996;545.
105. + thymocytes. Nature. 374:1995;474.
106. Zhang R., Alt F.W., Davidson L., Orkin S.H., Swat W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature. 374:1995;470.
107. Tarakhovsky A., Turner M., Schaal S., Mee P.J., Duddy L.P., Rajewsky K., Tubulewicz V.L. Defective antigen receptor-mediatefd proliferation of B and T cells in the absence of Vav. Nature. 374:1995;467.
108. Platanias L.C., Sweet M.E. Interferon α induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J Biol Chem. 269:1994;3143.
109. Uddin S., Sweet M.E., Colamonici O.R., Krolewski J.J., Platanias L.C. The vav proto-oncogene product interacts with the Tyk-2 protein tyrosine kinase. FEBS Lett. 403:1997;31.
110. Vav is associated to the IFNα/β receptor and contributes to the antiproliferative effect of IFNα in megacaryocytic cell lines. Eur Cyt Netw. 9:1998;356. (abstr).
111. Yetter A., Uddin S., Krolewski J.J., Jiao H., Yi T., Platanias L.C. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem. 270:1995;18179.
112. David M., Chen H.E., Goelz S., Larner A.C., Neel B.G. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol. 15:1995;7050.
113. David M., Zhou G., Pine R., Dixon J.E., Larner A.C. The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression. J Biol Chem. 271:1996;15862.
114. Shen S.H., Bastien L., Posner B.I., Chretien P. A protein tyrosine phosphatase with sequence similarity to the SH2 somain of the protein tyrosine kianses. Nature. 352:1991;736.
115. Yi T., Cleveland J.L., Ihle J.N. Protein tyrosine phosphatase containing SH2 domains. characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-13 Mol Cell Biol. 12:1992;836.
116. Plutzky J., Neel B.G., Rosenberg R.D. Isolation of a Src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci U S A. 89:1992;1123.
117. Matthews R.J., Bowne D.B., Flores E., Thomas M.L. Characterization of hematopoietic intracellular protein tyrosine phosphatases. Description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine rich residues Mol Cell Biol. 12:1992;2396.
118. Tsui H.W., Simonovitch K.A., de Souza L., Tsui F.W.L. Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase gene. Nature Gen. 4:1993;124.
119. Shultz L.D., Schweitzer P.A., Rajan T.V., Yi T., Ihle J.N., Matthews R.J., Thomas M.L., Beier D.R. Mutations of the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1993;1445.
120. You M., Yu D.H., Feng G.S. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol. 19:1999;2416.
121. Bach E.A., Tanner J.W., Marsters S., Ashkenazi A., Aguet M., Shaw A.S., Schreiber R.D. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol. 16:1996;3214.
122. Sakatsume M., Igarashi K., Winestock K.D., Garotta G., Larner A.C., Finbloom D.S. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J Biol Chem. 270:1995;17528.
123. Kaplan D.H., Greenlund A.C., Tanner J.W., Shaw A.S., Schreiber R.D. Identification of an interferon-gamma receptor alpha chain sequence required for JAK-1 binding. J Biol Chem. 271:1996;9.
124. Greenlund A.C., Farrar M.A., Viviano B.L., Schreiber R.D. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13:1994;1591.
125. Greenlund A.C., Morales M.O., Viviano B.L., Yan H., Krolewski J., Schreiber R.D. Stat recruitment by tyrosine-phosphorylated cytokine receptors. an ordered reversible affinity-driven process Immunity. 2:1995;677.
126. Shuai K., Stark G.R., Kerr I.M., Darnell J.E. Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science. 261:1993;1744.
127. Shuai K., Schindler C., Prezioso V.R., Darnell J.E. Jr. Activation of transcription by IFN-gamma. tyrosine phosphorylation of a 91-kD DNA binding protein Science. 258:1992;1808.
128. Stephens J.M., Lumpkin S.J., Fishman J.B. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J Biol Chem. 273:1998;31408.
129. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996 84:1996;431.
130. Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease Cell 84:443.
131. You M., Zhao Z. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells. J Biol Chem. 272:1997;23376.
132. Massa P.T., Wu C. The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-gamma signaling in neural cells. J Immunol. 157:1996;5139.
133. English B.K., Orlicek S.L., Mei Z., Meals E.A. Bacterial LPS and IFN-gamma trigger the tyrosine phosphorylation of vav in macrophages. evidence for involvement of the hck tyrosine kinase J Leukoc Biol. 62:1997;859.
134. Uddin S., Grumbach I., Yi T., Colamonici O.R., Platanias L.C. Interferon α activates the tyrosine kinase Lyn in hematopoietic cells. Br J Haematol. 101:1998;446.
135. Petricoin E.F. 3rd, Ito S., Williams B.L., Audet S., Stancato L.F., Gamero A., Clouse K., Grimley P., Weiss A., Beeler J., Finbloom D.S., Shores E.W., Abraham R., Larner A.C. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature. 390:1997;629.
136. Lund T.C., Medveczky M.M., Medveczky P.G. Interferon-α induction of Stats 1, -3 DNA binding and growth arrest is independent of Lck and active mitogen-activated kinase in T cells. Cell Immunol. 192:1999;133.
137. Takaoka A., Tanaka N., Mitani Y., Miyazaki T., Fujii H., Sato M., Kovarik P., Decker T., Schlessinger J., Tanigushi T. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFNγ, but not IFNα, signaling. EMBO J. 18:1999;2480.
138. Ding A., Hwang S., Schwab R. Effect of aging on murine macrophages. Diminished response to IFNγ for enhanced oxidative metabolism. J Immunol. 153:1994;2146.
139. Liu M.K., Brownsey R.W., Reiner N.E. Gamma interferon induces rapid and coordinate activation of mitogen-activated protein kinase (extracellular signal-regulated kinase) and calcium-independent protein kinase C in human monocytes. Infect Immunol. 62:1994;2722.
140. Sing K., Ballingand J.L., Fischer T.A., Smith T.W., Kelly R.A. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases. 1(and 2 (ERK1/ERK2) and STAT1α. J Biol Chem 271):1996;1111.
141. Kovarik P., Stoiber D., Novy M., Decker T. Stat1 combines signals derived from IFNγ and LPS receptors during macrophage activation. EMBO J. 17:1998;3660.
142. Wen Z., Zhong Z., Darnell J.E. Jr. Maximal activation of transcription by Stat1 and Stat-3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241.
143. Zhu X., Wen Z., Xu L.Z., Darnell J.E. Jr. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol. 17:1997;6618.
144. David M., Petricoin E. 3rd, Benjamin C., Pine R., Weber M.J., Larner A.C. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science. 269:1995;1721.